v3 Template
A

Antibody Solutions

Biopharmaceutical ~540 employees
Founded
--
Employees (Est.)
~540
27 leaders known
Total Funding
$1.2M
Funding Rounds
1
Last Funding
2024-04-04

About Antibody Solutions

Antibody Solutions is a biopharmaceutical company focused on advancing the discovery of better diagnostics and therapeutics by delivering fit-for-purpose antibodies. With over 25 years of history, they provide scientific expertise, rigorous project management, and a unique fee-for-service model that allows clients to retain their intellectual property.

Products & Services

Cellestive Discovery Platform:A platform for advanced antibody discovery.
Therapeutic Antibody Discovery:Services for discovering antibodies for therapeutic applications.
Transgenic Animal:Antibody discovery using transgenic animal models.
Alternative Antibody Modalities:Development of non-traditional antibody formats.
Critical Reagent Antibody:Discovery of antibodies for critical reagents.
Reagents for Diagnostic Assays:Provision of reagents for diagnostic purposes.
Antibody Discovery Services:Comprehensive services for antibody discovery.
Antigen Development:Development of antigens for antibody production.
FAbs & Fragments:Production of antibody fragments and FAbs.
Monoclonal Antibody Discovery:Discovery of monoclonal antibodies.
Molecular Modeling:Modeling services for antibody design.
Bioconjugation:Services for antibody conjugation.
Methods & Assays:Development of methods and assays for antibody research.

Specialties

Antibody Discovery Therapeutic Diagnostics Monoclonal and Polyclonal Antibodies Bioconjugation Molecular Modeling

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 1200000
MR: -
FA: nearly $1.2 million
FAN: 1200000
D: 2024-04-04
FD: 2024-04-04
1 investors
Grant Latest
2024-04-04
$1.2M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

John Kenney

President & Co-founder

J

Judith Lynch-Kenney

Chief Financial Officer & Co-founder

A

Allan Brooks

Operations Coordinator

D

Debra Valsamis

Business Development Manager

J

Jennifer Somera

Project Manager II

J

Jon Silver

Project Manager II

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Antibody Solutions Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~540 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro